Mitsui High-Tec, Inc. stock forecast
Want to see JP:6966 full AI Analyst Report?
Mitsui High-Tec, Inc. (6966) Stock Forecast & Price Target
6966 Analyst Ratings
6966 Stock 12 Month Forecast
Average Price Target
¥820.00▼(-5.53% Downside)Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Kota Yuzawa | Goldman Sachs | ¥720→¥820 | sell | -5.53%Downside | Reiterated | 09/09/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Kota YuzawaGoldman Sachs | SellReiterated¥720→¥820 | 09/09/26 | -5.53%Downside |
Best Analysts Covering Mitsui High-Tec, Inc.
Copying Kota Yuzawa's trades and holding each position for 3 Months would result in 40.00% of your transactions generating a profit, with an average return of -8.02% per trade.
Copying Kota Yuzawa's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of -0.72% per trade.
Copying Kota Yuzawa's trades and holding each position for 2 Years would result in 40.00% of your transactions generating a profit, with an average return of -4.20% per trade.
6966 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 1 | 1 | 1 |
In the current month, 6966 has received 0 Buy Ratings, 0 Hold Ratings, and 1 Sell Ratings. 6966 average Analyst price target in the past 3 months is 820.00.
6966 Financial Forecast
6966 Earnings Forecast
Next quarter’s earnings estimate for 6966 is JPY 16.96 with a range of JPY 16.96 to JPY 16.96. The previous quarter’s EPS was JPY 29.32. Its overall industry beat the EPS estimate 50.49% of the time in the past 12 months.
6966 Sales Forecast
Next quarter’s sales forecast for 6966 is JPY 66.60B with a range of JPY 66.60B to JPY 66.60B. The previous quarter’s sales results were JPY 68.79B. Its overall industry beat sales estimates 63.25% of the time in the past 12 months.
